PSMD10 and colorectal carcinoma: Statistical analysis revealed that Gankyrin expression significantly correlated with clinical stage (P = 0.003), T classification (P = 0.004), N classification (P < 0.001) and M classification (P = 0.015) in patients with CRC (Table 1).